Ionis Pharmaceuticals Inc IONS
10 trading plans running, 63 Form 144 notices for $144.7M
10-Q, 10-K and Form 144What IONS's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Nov 19, 2025 to Sep 30, 2028. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in |
|---|---|---|---|
| Shannon Devers Executive Vice President, Chief Human Resources Officer |
Ended 10b5-1 plan | Apr 14, 2026 | 10-Q Jul 29, 2026 |
| Frank Bennett Executive Vice President, Chief Scientific Officer |
Adopted 10b5-1 plan | Mar 31, 2026 | 10-Q Apr 29, 2026 |
| Holly Kordasiewicz Executive Vice President, Chief Development Officer |
Adopted 10b5-1 plan | Mar 13, 2026 | 10-Q Apr 29, 2026 |
| Eric Swayze Executive Vice President, Research |
Ended 10b5-1 plan | Mar 6, 2026 | 10-Q Apr 29, 2026 |
| Elizabeth Hougen Executive Vice President, Finance and Chief Financial Officer |
Adopted 10b5-1 plan | Dec 9, 2025 | 10-K Feb 26, 2026 |
| Joseph Wender Board Member |
Adopted 10b5-1 plan | Dec 9, 2025 | 10-K Feb 26, 2026 |
| Brett Monia Chief Executive Officer |
Adopted 10b5-1 plan | Dec 8, 2025 | 10-K Feb 26, 2026 |
| Kyle Jenne Executive Vice President, Chief Global Product Strategy Officer |
Adopted 10b5-1 plan | Dec 8, 2025 | 10-K Feb 26, 2026 |
| Patrick O'Neil Executive Vice President, Chief Legal Officer and General Counsel |
Ended 10b5-1 plan | Dec 8, 2025 | 10-K Feb 26, 2026 |
| Joseph Klein Board Member |
Adopted 10b5-1 plan | Nov 25, 2025 | 10-K Feb 26, 2026 |
| Shannon Devers Executive Vice President, Chief Human Resources Officer |
Adopted 10b5-1 plan | Nov 24, 2025 | 10-K Feb 26, 2026 |
| Joseph Baroldi Executive Vice President, Chief Business Officer |
Ended 10b5-1 plan | Nov 23, 2025 | 10-K Feb 26, 2026 |
| Eugene Schneider Executive Vice President, Chief Clinical Development and Operations Officer |
Adopted 10b5-1 plan | Nov 19, 2025 | 10-K Feb 26, 2026 |
| Frank Bennett Executive Vice President, Chief Scientific Officer |
Adopted 10b5-1 plan | Nov 19, 2025 | 10-K Feb 26, 2026 |
| Joseph Loscalzo Board Member |
Adopted 10b5-1 plan | Nov 18, 2025 | 10-K Feb 26, 2026 |
| Allene Diaz Board Member |
Ended 10b5-1 plan | Nov 17, 2025 | 10-K Feb 26, 2026 |
| B. Lynne Parshall Board Member |
Adopted 10b5-1 plan | May 6, 2025 | 10-Q Jul 30, 2025 |
| Frank Bennett Chief Scientific Officer |
Ended 10b5-1 plan | May 6, 2025 | 10-Q Jul 30, 2025 |
| Richard Geary Chief Development Officer |
Adopted 10b5-1 plan | May 6, 2025 | 10-Q Jul 30, 2025 |
| Eugene Schneider Chief Clinical Development and Operations Officer |
Adopted 10b5-1 plan | May 2, 2025 | 10-Q Jul 30, 2025 |
| Joseph Baroldi Chief Business Officer |
Adopted 10b5-1 plan | May 2, 2025 | 10-Q Jul 30, 2025 |
| Patrick O' Neil Chief Legal Officer and General Counsel |
Adopted 10b5-1 plan | May 2, 2025 | 10-Q Jul 30, 2025 |
| Spencer Berthelsen Director |
Adopted 10b5-1 plan | Sep 11, 2024 | 10-Q Nov 6, 2024 |
| Shannon L. Devers EVP, Chief Human Resources Officer |
Adopted 10b5-1 plan | Sep 3, 2024 | 10-Q Nov 6, 2024 |
| Brett P. Monia Chief Executive Officer |
Adopted 10b5-1 plan | Aug 12, 2024 | 10-Q Nov 6, 2024 |
| Brian Birchler EVP, Corporate and Development Operations |
Adopted 10b5-1 plan | Aug 12, 2024 | 10-Q Nov 6, 2024 |
| C. Frank Bennett EVP, Chief Scientific Officer |
Adopted 10b5-1 plan | Aug 12, 2024 | 10-Q Nov 6, 2024 |
| Eric Swayze EVP, Research |
Ended 10b5-1 plan | Aug 12, 2024 | 10-Q Nov 6, 2024 |
| Joseph Loscalzo Board Member |
Adopted 10b5-1 plan | Aug 12, 2024 | 10-Q Nov 6, 2024 |
| Brett P. Monia Chief Executive Officer |
Ended 10b5-1 plan | Jun 26, 2024 | 10-Q Aug 1, 2024 |
| Richard S. Geary EVP, Chief Development Officer |
Adopted 10b5-1 plan | Apr 8, 2024 | 10-Q Aug 1, 2024 |
| Patrick O'Neil Chief Legal Officer & General Counsel |
Ended 10b5-1 plan | Feb 14, 2024 | 10-Q May 7, 2024 |
| Elizabeth Hougen EVP, Finance & Chief Financial Officer |
Adopted 10b5-1 plan | Jan 12, 2024 | 10-Q May 7, 2024 |
| Eugene Schneider EVP, Chief Clinical Development and Operations Officer |
Adopted 10b5-1 plan | Jan 12, 2024 | 10-Q May 7, 2024 |
| Joseph Baroldi EVP, Chief Business Officer |
Adopted 10b5-1 plan | Jan 5, 2024 | 10-Q May 7, 2024 |
| B. Lynne Parshall Board Member |
Ended 10b5-1 plan | Jan 3, 2024 | 10-Q May 7, 2024 |
| Joseph Klein, III Board Member |
Adopted 10b5-1 plan | Jan 3, 2024 | 10-Q May 7, 2024 |
| B. Lynne Parshall Board Member |
Adopted 10b5-1 plan | Sep 27, 2023 | 10-Q Nov 2, 2023 |
| Spencer Berthelsen Board Member |
Adopted 10b5-1 plan | Sep 7, 2023 | 10-Q Nov 2, 2023 |
| Eric Swayze EVP, Research |
Adopted 10b5-1 plan | Jul 13, 2023 | 10-Q Nov 2, 2023 |
| Brett Monia CEO and Board Member |
Ended 10b5-1 plan | Jul 12, 2023 | 10-Q Nov 2, 2023 |
| C. Frank Bennett EVP, Chief Scientific Officer |
Adopted 10b5-1 plan | Jun 29, 2023 | 10-Q Aug 9, 2023 |
| Eric Swayze EVP, Research |
Ended 10b5-1 plan | Jun 28, 2023 | 10-Q Aug 9, 2023 |
| Allene Diaz Board Member |
Adopted 10b5-1 plan | May 3, 2023 | 10-Q Aug 9, 2023 |
Show the other 36 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 3, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Oct 16, 2026 | Devers Shannon L. Officer |
1,357 | $60K |
| Jul 7, 2026 | Diaz Allene M. Director |
10,111 | $864K |
| Jul 7, 2026 | Kordasiewicz Holly B. Officer |
1,287 | $108K |
| Jul 7, 2026 | BENNETT C FRANK Officer |
67,386 | $5.7M |
| Jul 1, 2026 | KLEIN JOSEPH III Director |
11,518 | $910K |
| Jun 26, 2026 | Baroldi Mariana Member of immediate family of any of the foregoing |
5,635 | $452K |
| Jun 26, 2026 | O'NEIL PATRICK R. Officer |
3,069 | $246K |
| Jun 26, 2026 | Schneider Eugene Officer |
47,884 | $3.9M |
| Jun 25, 2026 | Swayze Eric Officer |
10,602 | $839K |
| Jun 15, 2026 | BERTHELSEN SPENCER R Director |
8,000 | $588K |
| Jun 12, 2026 | Kordasiewicz Holly B. Officer |
60,846 | $4.5M |
| Jun 1, 2026 | BERTHELSEN SPENCER R Director |
8,000 | $605K |
| May 13, 2026 | Monia Brett P Officer |
100,000 | $7.8M |
| May 4, 2026 | LOSCALZO JOSEPH Director |
54,321 | $4.3M |
| Apr 28, 2026 | Baroldi Joseph Officer |
1,626 | $117K |
| Apr 16, 2026 | Jenne Kyle Officer |
4,902 | $370K |
| Apr 16, 2026 | Birchler Brian Officer |
973 | $73K |
| Apr 16, 2026 | Baroldi Joseph Officer |
5,619 | $424K |
| Mar 31, 2026 | Diaz Allene M. Director |
68,800 | $5.5M |
| Mar 24, 2026 | Schneider Eugene Officer |
5,812 | $412K |
| Mar 19, 2026 | Schneider Eugene Officer |
5,812 | $412K |
| Mar 16, 2026 | HOUGEN ELIZABETH L Officer |
225,200 | $16.3M |
| Mar 10, 2026 | Jenne Kyle Director |
58,253 | $4.4M |
| Mar 9, 2026 | O'NEIL PATRICK R. Officer |
13,217 | $995K |
| Mar 3, 2026 | BENNETT C FRANK Officer |
85,089 | $7.1M |
| Mar 3, 2026 | LOSCALZO JOSEPH Director |
24,000 | $1.9M |
| Mar 3, 2026 | Baroldi Mariana Officer |
8,198 | $656K |
| Mar 3, 2026 | Baroldi Joseph Officer |
4,096 | $325K |
| Mar 3, 2026 | KLEIN JOSEPH III Director |
65,345 | $5.0M |
| Mar 3, 2026 | Devers Shannon L. Officer |
39,014 | $3.1M |
| Feb 13, 2026 | Swayze Eric Officer |
15,642 | $1.3M |
| Feb 11, 2026 | PARSHALL B LYNNE Director |
10,000 | $827K |
| Feb 6, 2026 | Monia Brett P Officer |
290,203 | $24.8M |
| Feb 2, 2026 | BENNETT C FRANK Officer |
85,089 | $7.1M |
| Jan 30, 2026 | Baroldi Joseph Officer |
5,296 | $440K |
| Jan 30, 2026 | Birchler Brian Officer |
6,179 | $512K |
| Jan 30, 2026 | BENNETT C FRANK Officer |
5,885 | $488K |
| Jan 30, 2026 | HOUGEN ELIZABETH L Officer |
6,988 | $580K |
| Jan 30, 2026 | Monia Brett P Officer, Director |
62,970 | $5.2M |
| Jan 30, 2026 | O'NEIL PATRICK R. Officer |
6,179 | $513K |
| Jan 30, 2026 | Swayze Eric Officer |
6,179 | $513K |
| Jan 30, 2026 | Schneider Eugene Officer |
6,179 | $513K |
| Jan 23, 2026 | Devers Shannon L. Officer |
3,977 | $323K |
| Jan 22, 2026 | Devers Shannon L. Officer |
3,977 | $323K |
| Jan 21, 2026 | Baroldi Mariana Member of immediate family of any of the foregoing |
1,171 | $94K |
| Jan 16, 2026 | Swayze Eric Officer |
9,884 | $754K |
| Jan 16, 2026 | Baroldi Joseph Officer |
6,999 | $560K |
| Jan 16, 2026 | BENNETT C FRANK Officer |
8,977 | $684K |
| Jan 16, 2026 | Birchler Brian Officer |
8,480 | $646K |
| Jan 16, 2026 | HOUGEN ELIZABETH L Officer |
12,922 | $985K |
| Jan 16, 2026 | Monia Brett P Officer, Director |
44,034 | $3.4M |
| Jan 16, 2026 | Kordasiewicz Holly B. Officer |
4,141 | $315K |
| Jan 16, 2026 | O'NEIL PATRICK R. Officer |
9,191 | $701K |
| Jan 16, 2026 | Schneider Eugene Officer |
9,302 | $709K |
| Jan 16, 2026 | Jenne Kyle Officer |
1,823 | $139K |
| Jan 16, 2026 | Devers Shannon L. Officer |
8,353 | $637K |
| Jan 7, 2026 | Devers Shannon L. Officer |
9,390 | $795K |
| Jan 2, 2026 | Swayze Eric Officer |
23,463 | $1.6M |
| Dec 1, 2025 | Joseph Wender Director |
33,600 | $2.5M |
| Dec 1, 2025 | Joseph Wender Director |
14,479 | $1.2M |
| Nov 25, 2025 | Devers Shannon L. Officer |
42,322 | $3.4M |
| Nov 25, 2025 | KLEIN JOSEPH III Director |
12,000 | $960K |
| Nov 19, 2025 | Joan E. Herman Director |
44,000 | $3.3M |
Show the other 55 notices
From the Form 144 XML filed with the SEC, since Nov 19, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/IONS/export.csv") into a cell.